<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell J</journal-id><journal-id journal-id-type="iso-abbrev">Cell J</journal-id><journal-id journal-id-type="publisher-id">Royan Institute</journal-id><journal-title-group><journal-title>Cell Journal (Yakhteh)</journal-title></journal-title-group><issn pub-type="ppub">2228-5806</issn><issn pub-type="epub">2228-5814</issn><publisher><publisher-name>Royan Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">36043409</article-id><article-id pub-id-type="pmc">PMC9428480</article-id><article-id pub-id-type="other">Cell-J-24-410</article-id><article-id pub-id-type="doi">10.22074/cellj.2022.8051</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject><subj-group><subject>Genetics</subject><subject>Gynecology and Female Infertility</subject></subj-group></subj-group></article-categories><title-group><article-title><italic>TGF&#x000df;</italic> Gene Members and Their Regulatory Factors in Granulosa
Compared to Cumulus Cells in PCOS: A Case-Control Study </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alvandian</surname><given-names>Faezeh</given-names></name><degrees>M.Sc</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Hosseini</surname><given-names>Elham</given-names></name><degrees>Ph.D</degrees><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Hashemian</surname><given-names>Zohre</given-names></name><degrees>M.Sc</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Khosravifar</surname><given-names>Mona</given-names></name><degrees>M.Sc</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Movaghar</surname><given-names>Bahar</given-names></name><degrees>Ph.D</degrees><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Shahhoseini</surname><given-names>Maryam</given-names></name><degrees>Ph.D</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A7" ref-type="aff">7</xref><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name><surname>Shiva</surname><given-names>Marzieh</given-names></name><degrees>M.D</degrees><xref rid="A9" ref-type="aff">9</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Afsharian</surname><given-names>Parvaneh</given-names></name><degrees>Ph.D</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><aff id="A1"><label>1</label>Faculty of Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran</aff><aff id="A2"><label>2</label>Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</aff><aff id="A3"><label>3</label>Deputy of Research and Technology, Hamadam University of Medical Sciences, Hamadan, Iran</aff><aff id="A4"><label>4</label>Department of Obstetrics and Gynecology, Mousavi Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran</aff><aff id="A5"><label>5</label>Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran</aff><aff id="A6"><label>6</label>Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR,
Tehran, Iran</aff><aff id="A7"><label>7</label>Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</aff><aff id="A8"><label>8</label>Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran</aff><aff id="A9"><label>9</label>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive
Biomedicine, ACECR, Tehran, Iran</aff></contrib-group><author-notes><corresp id="cor1">
<label>*Corresponding Address:</label>
<addr-line>P.O.Box: 16635-148</addr-line>
<addr-line>Department of Endocrinology and Female Infertility</addr-line>
<addr-line>Reproductive Biomedicine Research Center</addr-line>
<institution>Royan Institute for Reproductive Biomedicine</institution>
<addr-line>ACECR</addr-line>
<addr-line>Tehran</addr-line>
<addr-line>Iran
Department of Genetics</addr-line>
<addr-line>Reproductive Biomedicine Research Center</addr-line>
<institution>Royan Institute for Reproductive Biomedicine</institution>
<addr-line>ACECR</addr-line>
<addr-line>Tehran</addr-line>
<country>Iran</country>
Emails:<email>m.shiva@royan-rc.ac.ir</email>,<email>p.afsharian@royan-rc.ac.ir</email>
</corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>27</day><month>7</month><year>2022</year></pub-date><volume>24</volume><issue>7</issue><fpage>410</fpage><lpage>416</lpage><history><date date-type="received"><day>20</day><month>4</month><year>2021</year></date><date date-type="accepted"><day>23</day><month>8</month><year>2021</year></date></history><permissions><copyright-statement>Any use, distribution, reproduction or abstract of this publication in any medium,
with the exception of commercial purposes, is permitted provided the original work is properly cited.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial 3.0 (CC BY-NC 3.0) License, which permits
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original
work is properly cited. </license-p></license></permissions><abstract><sec><title>Objective</title><p> Transforming growth factor-beta (TGF-&#x003b2;) superfamily and its members that include bone morphogenetic
protein 15 (BMP15), anti-Mullerian hormone (AMH), growth /differentiation factor-9 (GDF9), and their respective
receptors: BMPR1A, BMPR1B, and BMPR2 have been implicated as key regulators in various aspects of ovarian
function. The abnormal function of the ovaries is one of the main contributing factors to polycystic ovarian syndrome
(PCOS), so this study aimed to investigate the mRNA expression profile of these factors in granulosa (GCs) and
cumulus cells (CCs) of those patients.
</p></sec><sec><title>Materials and Methods</title><p> The case-control research was conducted on 30 women (15 infertile PCOS and 15
normo-ovulatory patients, 22&#x02264;age &#x02264;38 years old) who underwent ovarian stimulation for in vitro fertilization (IVF)/
intracytoplasmic sperm injection (ICSI) cycle. GCs/CCs were obtained during ovarian puncture. The expression
analysis of the aforementioned genes was quantified using real-time polymerase chain reaction (PCR).
</p></sec><sec><title>Results</title><p> AMH and BMPR1A expression levels were significantly increased in GCs of PCOS compared to the control group.
In contrast, GDF9, BMP15, BMPR1B, and BMPR2 expressions were decreased. PCOS' CC showed the same expression
patterns. GDF9 and AMH were effectively expressed in normal CCs, and <italic>BMP15</italic> and <italic>BMPR1B</italic> in normal GCs (P&#x0003c;0.05).
</p></sec><sec><title>Conclusion</title><p>Differential gene expression levels of <italic>AMH</italic> and its regulatory factors and their primary receptors were
detected in granulosa and cumulus cells in PCOS women. Since the same antagonist protocol for ovarian stimulation
was used in both PCOS and control groups, the results were independent of the protocols. This diversity in gene
expression pattern may contribute to downstream pathways alteration of these genes, which are involved in oocyte
competence and maturation.</p></sec></abstract><kwd-group><kwd>Cumulus Cell</kwd><kwd>Granulosa Cell</kwd><kwd>Polycystic Ovarian Syndrome</kwd><kwd>TGF-Beta Superfamily</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>Citation</meta-name><meta-value>Alvandian F, Hosseini E, Hashemian Z, Khosravifar M, Shiva M, Movaghar B, Shahhoseini M, Afsharian P. TGF&#x003b2; gene members and their regulatory
factors in granulosa compared to cumulus cells in PCOS: a case-control study. Cell J. 2022; 24(7): 410-416. doi: 10.22074/cellj.2022.8051.
This open-access article has been published under the terms of the Creative Commons Attribution Non-Commercial 3.0 (CC BY-NC 3.0).</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Polycystic ovary syndrome (PCOS), one of the most
common causes of an-ovulatory, is a heterogeneous
endocrine disorder in infertile women, affecting up to
6-20% of women of reproductive age (<xref rid="B1" ref-type="bibr">1</xref>).</p><p>PCOS is confirmed by existing at least two of three
special features based on the Rotterdam criteria:
clinical/ biochemical evidence of hyperandrogenism,
oligomenorrhea/ anovulation, and polycystic ovaries (<xref rid="B2" ref-type="bibr">2</xref>).
A wide variety of genetic alterations in differential tissues
and cell types impact normal follicular development in
this syndrome. Imbalanced follicle-stimulating hormone
(FSH), luteinizing hormone (LH), and some key factors
that are involved in the inappropriate progression of
folliculogenesis are the main molecular features associated
with impaired and arrested development of the germinal
vesicle stage of oocytes toward the dominant and mature
follicles in polycystic ovaries (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>).
</p><p>The delicate communication process between different
types of cells in the mammalian follicles, namely oocyte
and its surrounding somatic cells, granulosa (GCs), and
cumulus cells (CCs), has a pivotal impact on the oogenesis
process, oocyte maturation, cumulus expansion, and
ovulation (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Paracrine signals of the oocyte are the
potent stimulators in GCs/CCs, which regulate the above
physiological processes and consequently affect female
fertility (<xref rid="B7" ref-type="bibr">7</xref>).</p><p>Among the secreted factors by the oocyte or follicle somatic cells, transforming growth
factor-beta (TGF-&#x003b2;) superfamily and its members, including anti-mullerian hormone
(<italic>AMH</italic>), growth and differentiation factor 9 (<italic>GDF9</italic>), and
bone morphogenetic protein 15 (<italic>BMP15</italic>) which are expressed in follicular
stage-related manner, have been implicated as key regulators in various aspects of
intra-ovarian development (<xref rid="B8" ref-type="bibr">8</xref>). On the other hand, alteration in expression of these factors,
especially <italic>AMH</italic>, is related to pathological ovarian conditions, such as PCOS
and Endometriosis (<xref rid="B9" ref-type="bibr">9</xref>).</p><p>AMH is now a quantitative marker of ovarian reserve as
well as a diagnostic factor for PCOS (<xref rid="B10" ref-type="bibr">10</xref>). TGF-&#x003b2; family
members bind to their receptors in GCs/CCs which induces
a cascade of several downstream protein-coding genes.
Even though GCs are differentiated into CCs and both of
them have a common progenitor during folliculogenesis,
the mentioned genes show different expression and even
regulation patterns in those specialized cell types (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>).
</p><p>Based on previous studies, alterations in the gene
expression pattern of granulosa-cumulus cells play a
definite role in the impaired final maturation of antral
follicles to later-stage growth, which is one of the main
contributing factors and underlying causes of polycystic
ovaries (<xref rid="B13" ref-type="bibr">13</xref>).</p><p>AMH is secreted from ovarian cells in the growing
follicles and can regulate the FSH-dependent follicle
development. Previous studies showed that the expression
and secretion of AMH from granulosa-cumulus cells are
increased in preovulatory follicles, which contain atretic
oocytes (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>).</p><p>GDF-9 and BMP-15, as other members of the TGF-&#x003b2;
superfamily, are known as growth promoters during normal
folliculogenesis (<xref rid="B16" ref-type="bibr">16</xref>). A study of intraovarian interactions,
regulatory mechanisms, and possible abnormalities
which interfere with the balance between these molecular
factors in patients suffering PCOS compared to women
with normal oogenesis can provide a better overview of
controlling and monitoring ovarian function that may be
resulted in improving the fertility of such patients.</p><p>This study aimed to investigate the mRNA expression profile of <italic>BMP15, GDF9, AMH</italic>
genes, and their respective receptors, which include: <italic>BMPR1A, BMPR1B</italic>, and
<italic>BMPR2</italic>, in GCs and CCs of PCOS patients, compared to women with normal
oogenesis undergoing controlled ovarian stimulation (COS) treatment cycles.</p></sec><sec sec-type="materials-methods"><title>Materials and Methods</title><p>The case-control research was endorsed by the
Royan Institute Ethics Boards (IR.ACECR.ROYAN.
REC.1394.86). Thirty patients (15 PCOS patients with
infertility and 15 normo-ovulatory patients, 22&#x02264;age&#x02264;38
years old) were recruited to the study between November
2014 and April 2016 who underwent COS for IVF/ICSI
at the Infertility Clinic (Royan Institute, Iran). Informed
consent were obtained from all subjects.</p><p>Patients who met the following criteria were included in
the control group: absence of clinical/ biochemical signs of
hyperandrogenism or other endocrine diseases, polycystic
ovaries, diabetes, with regular menstrual cycles (26&#x0003c;cycle
length&#x0003c;32), having normal hormone profile (TSH, FSH,
and LH). All controls were undergoing ovarian stimulation
treatment due to their tubal factor infertility. </p><p>Rotterdam diagnostic criteria are routinely used for PCOS phenotyping which includes:
chronic oligo and/ or anovulation (&#x0003c;26 or &#x0003e;35 days of cycle length), biochemical or
clinical evidence of hyperandrogenism (total testosterone concentration &#x0003e;0.5 ng/ml,
hirsutism, acne, and alopecia), and the presence of 12 or more ovarian cysts with 2-10 mm
diameter per cyst and/or ovarian volume &#x02265;10 cm<sup>3</sup> on ultrasound (polycystic
ovaries). </p><p>Inclusion criteria for all women (PCOS and control) were including the first IVF/ICSI
cycle, ovarian stimulation by antagonist protocol, 22&#x02264;age&#x02264;38 years, and body mass index
(BMI) of 18-28 kg/m<sup>2</sup> . The severe male factor, including
oligo-astheno-teratozoospermia, retrieved sperm from testis, and semen freeze was excluded.
The semen was analyzed in accordance with the criteria of the 5<sup>th</sup> edition of the
World Health Organization (WHO) in 2010.</p><p>All hormone tests (FSH and LH levels) were carried out on days 2 to 3 of the menstrual
cycle using electrochemiluminescence immunoassay kits (ECLIA kits, Roche Diagnostics GmbH,
Germany). Further evaluation of total testosterone concentrations in PCOS patients was
performed by using ELISA kits (Monobind Inc., USA), and serum AMH levels were assessed using
an electrochemiluminescence immunoassay by Elecsys<sup>&#x000ae;</sup> and Cobas Immunoassay
Analyzers (Roche GmbH).</p><sec><title>Control ovarian stimulation protocol</title><p>Down-regulation of the pituitary gland with GnRH
antagonist protocol [the administration of 75&#x02013;150 IU
recombinant FSH (Gonal F; Merck Serono, or Puregon;
MSD, the Netherlands)] was done for all women up to the
day of human chorionic gonadotropin (hCG, Ovitrelle&#x000ae;,
Merck-Serono) injection. The COS was performed
considering the age of the women and the antral follicle
count (AFC).</p></sec><sec><title>Granulosa and cumulus cells isolation
</title><p>The following steps were taken to isolate the follicular fluid and extract cumulus and
granulosa cells from collected cumulus-oocyte complex (COC) as described previously (<xref rid="B17" ref-type="bibr">17</xref>,
<xref rid="B18" ref-type="bibr">18</xref>). Briefly, follicular fluid (FF) was obtained after hCG injection (34-36 hours) during
ovarian puncture. COCs were collected from FF and repeatedly washed in culture medium
G1V5&#x02122; (Vitrolife AB, Sweden), then incubated at 37&#x000b0;C and 5% CO<sub>2 </sub>. Just before
ICSI, the COC was denuded with hyaluronidase enzyme, then CCs washed in free enzyme
medium, and cold phosphate buffered saline (PBS), then the cells were pelleted by
centrifugation twice for 8 minutes at 3000 rpm; the pellet was snap-frozen in liquid
nitrogen then stored at -80&#x000b0;C (<xref rid="B17" ref-type="bibr">17</xref>).</p><p>After retrieval of COCs, aspirated FF was centrifuged
for 10 minutes at 2000 rpm. The clear supernatant
(without blood) was isolated, the pellet was solved in
Tyrode&#x02019;s solution, and the suspension was added on
Sill select gradient and centrifuged at 3000 rpm for 13
minutes. Granulosa cells (The layer formed between
Sill select gradient and supernatant) were removed and
washed with 3 ml of DMEM / HamF12 medium 10%. In
the next step, the suspensions were centrifuged at 3000
rpm for 13 minutes. Afterward, the diluted hyaluronidase
enzyme was added, and the suspension was incubated for
3 minutes; a culture medium was added to neutralize the
effect of the enzyme, then the suspension was centrifuged
for 5 minutes at 1500 rpm; Red blood cell lysing buffer
was added to the cell suspension and incubated for 5
minutes, the solution was removed; granulosa cells were
taken for extraction of RNA.</p></sec><sec><title>RNA extraction, cDNA synthesis, and reverse
transcription-polymerase chain reaction (RT-PCR)</title><p>Total RNA was extracted, then purified by removing
DNA genomic from the samples using the RNeasy Micro
Kit (Qiagen, cat. no: 74004) as per the &#x02018; &#x02018;manufacturer&#x02019;s
protocol which is also previously described (<xref rid="B18" ref-type="bibr">18</xref>).</p><p>After assessment of RNA quantity and quality by
using the NanoDrop spectrophotometer (NanoDrop 2000
spectrophotometer), cDNA was synthesized using 20
nanograms of total RNA according to QuantiTect Whole
Transcriptome Kit (Qiagen, Cat.No:207045) instruction
and stored at -20&#x02218;
C until molecular analysis. </p><p>For granulosa cells&#x02019; RNA extraction, TRIzol Reagent
(Sigma- Aldrich) was used following the &#x02018; &#x02018;manufacturer&#x02019;s
protocol. Genomic DNA contaminations were removed
from all extracted RNA samples by treating them by
DNaseI (Fermentas, Thermo Scientific, Germany).
DNase I enzyme was inactivated by incubation for
7 minutes at 65&#x02218;
C with EDTA (50 mM, Fermentas,
Germany). The purity of RNA was detected by NanoDrop
spectrophotometer to determine A260/A280 ratio. RNA
(1 &#x000b5;g) was reverse transcribed to cDNA using firststrand cDNA synthesis kit (K1632- Fermentas, Thermo
Scientific, Germany) instruction, then stored at -20&#x02218;
C
until molecular analysis.</p></sec><sec><title>Quantitative real time-polymerase chain reaction</title><p>A quantitative mRNA analysis was performed using the Step-One RT-PCR system for doing
qRT-PCR (Applied Biosystems, USA). All reactions were run in duplicate. Evaluation of mRNA
gene expression of <italic>GDF9, BMP15, AMH, BMPR1A, BMPR1B, BMPR2 </italic>between the
patient and control groups was done by calculation of &#x02206;C<sub>t</sub> and 2<sup>-&#x02206;Ct</sup>.
To perform this analysis, cDNAs were synthesized from granulosa and cumulus cells of
patients and healthy individuals. The qPCR was performed with humanspecific primers. The
product size and primer sets are listed in <xref rid="T1" ref-type="table">Table 1</xref>. <italic>GAPDH</italic> primer was used
as a control gene expression. PCR products were visualized using Gel Red ZellBio, Germany)
staining and electrophoreses (1.7%-2% agarose, Paya pazhoh pars, Iran) under UV light by
Molecular Imager<sup>&#x000ae;</sup> Gel Doc&#x02122; XR+ (BioRad, USA).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Sequence of the primers used for quantitative polymerase chain reaction (qPCR) experiments</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1">
<hr/>
</th></tr><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Primer sequence (5&#x02032;&#x02192;3&#x02032;)</th><th rowspan="1" colspan="1">Annealing temperature (&#x000b0;C)</th><th rowspan="1" colspan="1">Size (bp)</th></tr><tr><th colspan="4" rowspan="1">
<hr/>
</th></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>GDF9</italic>
</td><td rowspan="1" colspan="1">F: AGAAGTCACCTCTACAACACTG</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">132</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R: AACGGTAGTAATGCGATCCA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>BMP15</italic>
</td><td rowspan="1" colspan="1">TGTGAACTCGTGCTTTTCATG</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">102</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R: CTCAATCAGGGGCAAAGTAGG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>AMH</italic>
</td><td rowspan="1" colspan="1">AAGCTGCTCATCAGCCT</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">194</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R: TGCTTGCTGGTCTTTATTGG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>BMPR1A</italic>
</td><td rowspan="1" colspan="1">GAACTATTGCCAAACAGATTCAGA</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">200</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R: TGCCGCTATGAAACCAAGTAT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>BMPR1B</italic>
</td><td rowspan="1" colspan="1">ATTTGCAGCACAGACGGATATTGTT</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">199</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R: GAGGCAGTGTAGGGTGTAGGTCTT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>BMPR2</italic>
</td><td rowspan="1" colspan="1">TGCCGCTATGAAACCAAGTAT</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">184</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R: GACTCACCTATCTGTATACTGCT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>GAPDH</italic>
</td><td rowspan="1" colspan="1">AGAAGGCTGGGGCTCATTTG</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">228</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R: TGATGGCATGGACTGTGGT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><th colspan="4" rowspan="1">
<hr/>
</th></tr></tbody></table></table-wrap></sec><sec><title>Statistical analysis </title><p>Data obtained were analyzed using the Independent
Samples t test, using IBM SPSS software version 22.
The one-sample Kolmogorov-Smirnov (K-S) test was
used to determine whether the variables come from the
normal distribution in each group. Data are presented as
mean &#x000b1; SD at the level of P&#x0003c;0.05.
</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Demographic information</title><p>Table 2 presents all the demographic data. Age, BMI,
and duration of infertility were similar between the
PCOS and control groups (P&#x0003e;0.05). However, there were
significant differences among them considering the main
PCOS features and characteristics, such as the ratio of LH/
FSH, LH and AMH levels (<xref rid="T2" ref-type="table">Table 2</xref>). The PCOS subjects
showed higher LH level than normo-ovulatory females
(control group) (P&#x0003c;0.01).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Demographic information</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1">
<hr/>
</th></tr><tr><th rowspan="1" colspan="1">Parameters</th><th rowspan="1" colspan="1">PCOS group</th><th rowspan="1" colspan="1">Control group</th><th rowspan="1" colspan="1">P value</th></tr><tr><th colspan="4" rowspan="1">
<hr/>
</th></tr><tr><td align="left" rowspan="1" colspan="1">Age (Y)</td><td rowspan="1" colspan="1">28.87 &#x000b1; 6.5</td><td rowspan="1" colspan="1">28.87 &#x000b1; 6.5</td><td rowspan="1" colspan="1">0.9</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">24.5 &#x000b1; 4.5</td><td rowspan="1" colspan="1">25.82 &#x000b1; 4.5</td><td rowspan="1" colspan="1">0.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Infertility duration (Y)</td><td rowspan="1" colspan="1">2.5-10</td><td rowspan="1" colspan="1">3-15</td><td rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of oocyte</td><td rowspan="1" colspan="1">11.5 &#x000b1; 4.5</td><td rowspan="1" colspan="1">8 &#x000b1; 3</td><td rowspan="1" colspan="1">0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">AMH (ng/&#x000b5;l)</td><td rowspan="1" colspan="1">12.43 &#x000b1; 5.9<sup>*</sup></td><td rowspan="1" colspan="1">4.7 &#x000b1; 2.9</td><td rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">FSH (IU/I)</td><td rowspan="1" colspan="1">6.71 &#x000b1; 3.3</td><td rowspan="1" colspan="1">6.42 &#x000b1; 3.15</td><td rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">LH (IU/I)</td><td rowspan="1" colspan="1">14.35 &#x000b1; 11.55<sup>*</sup></td><td rowspan="1" colspan="1">3.85 &#x000b1; 3.35</td><td rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">TSH (IU/I)</td><td rowspan="1" colspan="1">2.23 &#x000b1; 1.65</td><td rowspan="1" colspan="1">2.45 &#x000b1; 2.15</td><td rowspan="1" colspan="1">0.5</td></tr><tr><th colspan="4" rowspan="1">
<hr/>
</th></tr></tbody></table><table-wrap-foot><fn><p>The results are reported as mean &#x000b1; SD. AMH; Anti-mullerian hormone, BMI; Body mass index, FSH; Follicle-stimulating hormone, TSH; Thyroid stimulating
hormone, and *; P&#x0003c;0.05.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>The expression level of <italic>GDF9, BMP15, AMH</italic> and their receptors in GCs
and CCs from PCOS women compared to non-PCOS women</title><p>As shown in <xref rid="F1" ref-type="fig">Figure 1</xref>, all amplified RT-PCR products were at the expected size for
<italic>GDF9, BMP15, AMH, BMPR1B, BMPR1A</italic>, and <italic>BMPR2</italic> genes. </p><p>In GCs isolated from PCOS subjects, an overexpression of <italic>AMH</italic>
(P&#x0003c;0.001) and <italic>BMPR1A</italic> (P&#x0003c;0.001) was observed. In contrast,
the level of <italic>GDF9</italic> (P&#x0003e;0.001), <italic>BMP15, BMPR1B,</italic> and
<italic>BMPR2</italic> gene expression were significantly decreased (P&#x0003c;0.001,
<xref rid="F2" ref-type="fig">Fig .2A</xref>).</p><p>On the other hand, CCs from PCOS patients display the same patterns as observed in
GCs genes expression increased expression of <italic>AMH</italic> (P&#x0003c;0.001) and
<italic>BMPR1A</italic> (P&#x0003c;0.038); decreased expression of <italic>GDF9</italic>
(P&#x0003c;0.001), <italic>BMP15</italic> (P=0.005), <italic>BMPR1B</italic>
(P&#x0003c;0.004), and <italic>BMPR2</italic> (P&#x0003c;0.001) mRNA significantly
(<xref rid="F2" ref-type="fig">Fig .2B</xref>).</p><fig position="float" id="F1"><label>Fig 1</label><caption><p>Results of RT-PCR for mRNA expression of <italic>GDF9, BMP15, AMH, BMPR1B, BMPR1A</italic>, and
<italic>BMPR2</italic> genes (DNA ladder 50 base pair). RT-PCR; Reverse
transcription polymerase chain reaction.</p></caption><graphic xlink:href="Cell-J-24-410-g01" position="float"/></fig><fig position="float" id="F2"><label>Fig 2</label><caption><p>Expression level of <italic>GDF9, BMP15, AMH</italic> and their receptors in polycystic ovarian
syndrome (PCOS) women and control group. <bold>A. </bold>Gene expression of granulosa
cell from PCOS women compared to control group. <bold>B.</bold> Gene expression of
cumulus cells from PCOS women compared to control group.</p></caption><graphic xlink:href="Cell-J-24-410-g02" position="float"/></fig><fig position="float" id="F3"><label>Fig 3</label><caption><p>Differential gene expression profile in granulosa compared to cumulus cells. <bold>A. </bold>Gene
expression profile in granulosa cells compared to cumulus cells in polycystic ovarian
syndrome (PCOS) group. <bold>B.</bold> Gene expression profile in granulosa cells
compared to cumulus cells in control groups.</p></caption><graphic xlink:href="Cell-J-24-410-g03" position="float"/></fig></sec><sec><title>Differential gene expression profile in GCs compared
to CCs in control and PCOS women</title><p>Comparing CCs and GCs from PCOS patients
revealed GDF9, BMP15 (P&#x0003c;0.05) and AMH (P&#x0003c;0.001)
have higher expression in cumulus cells; in contrast,
BMPR1A (P&#x0003c;0.05) expression level is higher in GCs
of such patients (<xref rid="F3" ref-type="fig">Fig .3A</xref>). On the other hand, BMP15
(P&#x0003c;0.001) and BMPR1B (P&#x0003c;0.03) are effe&#x02206;ively
expressed in normal granulosa cells compared to
normal CCs, and AMH (P&#x0003c;0.001) and GDF9 (P&#x0003c;0.001)
have higher mRNA expression in CCs of control than
PCOS patients (<xref rid="F3" ref-type="fig">Fig .3B</xref>).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The differential gene expression levels of <italic>AMH</italic> and its regulatory factors
that include <italic>BMP15</italic> and <italic>GDF9</italic>, as well as their primary
receptors: <italic>BMPR2, BMPR1B</italic>, and <italic>BMPR1A</italic>, were detected in
granulosa and cumulus cells in PCOS women compared to the control group. In addition, these
genes showed different expression patterns in two ovarian cells (GCs and CCs). </p><p>Granulosa cells show phenotypic heterogeneity in the
developing ovarian Follicle. During folliculogenesis, the
heterogeneous GC populations differentiate and divide
into mural GCs and CCs. Their function is associated
with their position in the follicles and proximity to
the oocyte resulting in different properties and gene
expression patterns (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>). The mural GCs have a great
steroidogenic function, a high level of LH receptors, and
mainly are involved in the acquisition of signals from
outside Follicle; however, the cumulus cells provide
essential regulatory factors for oocytes to promote final
cytoplasmic and nuclear maturation (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). </p><p>The resumption of oocyte meiosis is regulated by activating some genes in the oocyte itself
and a broad signaling network in other follicular cells (<xref rid="B23" ref-type="bibr">23</xref>). The increased expression of
<italic>BMP15</italic> and <italic>BMPR1B </italic>receptors in the periovulatory phase of
ovarian cells showed their implication in the ovulatory process. On the other hand, these
BMP proteins, the largest subfamily belonging to the TGF&#x003b2; superfamily, regulate numerous
main biological processes in the ovarian follicle, including cell differentiation,
proliferation, and apoptosis (<xref rid="B24" ref-type="bibr">24</xref>). Also, the expression of <italic>BMPR1B</italic> is
correlated with serum oestradiol (E2) level in normal folliculogenesis (<xref rid="B25" ref-type="bibr">25</xref>). Alterations in
BMPs signaling are involved in some folliculogenesis disorders such as PCOS (<xref rid="B24" ref-type="bibr">24</xref>). In
<italic>Bmp15</italic> knockout mice, uni- and bi-lateral cysts developed, ovulation rate
was decreased and female mice were subfertile due to reduced developmental potential of
oocytes and ovulation (<xref rid="B26" ref-type="bibr">26</xref>). The reduced expression of this ligand and its receptor in PCOS
patients, as shown in the present study, has revealed the association mechanism of
PCOS-related anovulation and impaired oocyte competency and maturation.</p><p>The study performed by Kedem-Dickman et al. (<xref rid="B27" ref-type="bibr">27</xref>) showed a reverse association between GC
-cumulus <italic>AMH</italic> expression and oocyte maturity in preovulatory follicles. It
means that corresponding GC-cumulus cells of the Germinal Vesicle oocyte stage express
higher AMH mRNA levels than the Metaphase stage ones. They suggested that AMH meiosis
inhibition, which had been confirmed previously (<xref rid="B28" ref-type="bibr">28</xref>), was the mechanism by which the oocytes
may fail to resume meiosis. </p><p>Some recent studies showed that high levels of AMH decrease the FSH receptors number and
reduces the sensitivity of GC to FSH, which consequently prevents the provoke activation of
critical genes in steroidogenesis processes such as <italic>P450scc</italic> and
<italic>CYP19A1</italic> genes (<xref rid="B29" ref-type="bibr">29</xref>).</p><p>PCOS is a disease in which AMH has putative roles in
its pathophysiology (<xref rid="B30" ref-type="bibr">30</xref>). Usually, it is the first cause of
anovulation infertility in women (<xref rid="B31" ref-type="bibr">31</xref>). It seems that AMH
contributes to the mechanisms leading to antral follicle
arrest, anovulation, and oligomenorrhoea/ amenorrhoea
(<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Taken together, these studies suggest that
increased AMH levels in PCOS women create an AMHdominated microenvironment, which counteracts the
action of FSH on follicles selection (<xref rid="B34" ref-type="bibr">34</xref>). The increased
pre-antral follicle number, which is the primary source of
AMH, is not merely contributing factor, but also elevated
AMH concentration in PCOS is largely due to increased
AMH production by individual follicles (<xref rid="B35" ref-type="bibr">35</xref>).</p><p>These studies have shown indirect confirmation of AMH&#x02019;s role in PCOS. Further observations
elucidated the mechanism by which <italic>AMH</italic> expression is up-regulated in GCs. A
limited number of BMPs such as BMP15 can bind to BMPR1B and BMPR2 receptors, and the
activated receptors recognize SMAD1, which is translocated to the AMH promoter sequence.
This mechanism significantly causes the <italic>AMH</italic> expression induction in human
GCs (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>). In our study, mRNA expression of BMP15 in cumulus cells of PCOS patients is
higher than in granulosa ones, and <italic>AMH</italic> expression was also higher in these
cells. However, when CCs/GCs of PCOS are compared to normal oogenesis ones, this pattern was
not observed. The high level of <italic>AMH</italic> expression in PCOS may be due to an
additional source of BMP15 secretion, especially from the corresponding oocyte, which could
induce <italic>AMH</italic> expression in CCs/GCs of such patients.</p><p>In PCOS, however, <italic>BMPR1A</italic> in GCs and <italic>GDF9, BMP15</italic> and
<italic>AMH</italic> in CCs have a substantial expression. These distinct alterations in
the follicular microenvironment of PCOS patients may negatively interfere with
intra-follicular signals such as the follicle sensitivity to FSH, compromise the dominant
follicle selection and the other functions of the GC/CC cells from the viewpoint of the
oocyte maturation aspect and reproductive processes (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). </p><p>On the other hand, in ovarian cells, the most important
receptor for AMH is BMPR-1A. Therefore some members
of the TGF-&#x003b2; superfamily share their signaling pathway with
AMH, and target genes involved in folliculogenesis and GCs
differentiation could also be regulated by AMH (<xref rid="B40" ref-type="bibr">40</xref>). </p><p>To explore whether gene expression pattern is diverse between cumulus cells and granulosa
cells, we analyzed the expression profile. Data showed a differential overexpression of
GDF9, <italic>BMP15</italic>, and <italic>AMH</italic> in infertile PCOS cumulus cells in
comparison to PCOS granulosa cells. However, <italic>AMH</italic> and <italic>GDF9</italic>
have the same pattern in normal cyclic cumulus cells, but <italic>BMP15</italic> and
<italic>BMPR1B</italic> significantly decreased in granulosa cells of normal patients.
Therefore, the gene expression profile in both GC and CC cells showed interesting diversity.
Since the same antagonist protocol for ovarian stimulation was used in both PCOS and control
groups, the results were independent of the protocols.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>To conclude, based on the previous results, increased gene expression of
<italic>AMH</italic> and <italic>BMPR1A</italic> and decreased gene expression of
<italic>GDF9, BMP15</italic>, and <italic>BMPR1B</italic> may contribute to alterations in
the downstream pathway, which are involved in ovulatory function, follicular growth, and
oocyte maturation. The results of the current study are important for understanding the
mechanisms of follicular growth arresting and anovulation cycles in patients suffering from
PCOS. It will be considered to screen the epigenetic regulatory mechanism of the promoter
regions of the TGF&#x003b2; family members and corresponding receptors in future studies. </p></sec></body><back><ack><title>Acknowledgements</title><p>This study was financially sponsored by the Genetics
Department of Royan Institute Tehran, Iran. The authors
dedicate this article to the memory of Dr. Saeid Kazemi
Ashtiani, the late founder of Royan Institut. There is no
conflict of interest.</p></ack><bio id="d64e893"><title>Authors&#x02019; Contributions</title><p>F.A., P.A., M.Shi, M.Sha, E.H.; Contributed to conception
and design. F.A.; Contributed to all experimental work,
data and statistical analysis, and interpretation of data.
P.A., M.Shi.; Were responsible for overall supervision.
B.M., M.Shi.; Cooperated in the sampling section. M.Shi.;
Was responsible for patients assessment and diagnosis,
also for patient recruitment to study. F.A.; Collected the
sample. Z.H., M.Kh.; Cooperated with some experimental
tests. F.A., E.H.; Drafted the initial manuscript and wrote
the manuscript. P.A., E.H., M.Shi.; Contributed to revise
and edit the manuscript. All authors read and approved
the final manuscript.</p></bio><ref-list><ref id="B1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Lizneva</surname><given-names>D</given-names></name>
<name><surname>Atabiekov</surname><given-names>I</given-names></name>
<name><surname>Azziz</surname><given-names>R</given-names></name>
</person-group><part-title>Polycystic ovary syndrome</part-title><person-group person-group-type="editor">
<name><surname>skinner</surname><given-names>MK</given-names></name>
</person-group><source>encyclopedia of reproduction (second edition)</source><edition>Oxford</edition><publisher-name>Academic Press</publisher-name><year>2018</year><fpage>59</fpage><lpage>69</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alzamil</surname><given-names>H</given-names></name>
<name><surname>Aloraini</surname><given-names>K</given-names></name>
<name><surname>AlAgeel</surname><given-names>R</given-names></name>
<name><surname>Ghanim</surname><given-names>A</given-names></name>
<name><surname>Alsaaran</surname><given-names>R</given-names></name>
<name><surname>Alsomali</surname><given-names>N</given-names></name>
<etal/>
</person-group><article-title>Disparity among Endocrinologists and Gynaecologists in the Diagnosis of Polycystic Ovarian Syndrome</article-title><source>Sultan Qaboos Univ Med J</source><year>2020</year><volume>20</volume><issue>3</issue><fpage>e323</fpage><lpage>e329</lpage><pub-id pub-id-type="pmid">33110648</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arroyo</surname><given-names>A</given-names></name>
<name><surname>Kim</surname><given-names>B</given-names></name>
<name><surname>Yeh</surname><given-names>J</given-names></name>
</person-group><article-title>Luteinizing hormone action in human oocyte maturation and quality: signaling pathways, regulation, and clinical impact</article-title><source>Reprod Sci</source><year>2020</year><volume>27</volume><issue>6</issue><fpage>1223</fpage><lpage>1252</lpage><pub-id pub-id-type="pmid">32046451</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Albu</surname><given-names>D</given-names></name>
<name><surname>Albu</surname><given-names>A</given-names></name>
</person-group><article-title>The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes&#x02019; number and competence</article-title><source>Biosci Rep</source><year>2020</year><volume>40</volume><issue>1</issue><fpage>BSR20190811</fpage><lpage>BSR20190811</lpage><pub-id pub-id-type="pmid">31850491</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burnik Papler</surname><given-names>T</given-names></name>
<name><surname>Vrtacnik Bokal</surname><given-names>E</given-names></name>
<name><surname>Lovrecic</surname><given-names>L</given-names></name>
<name><surname>Kopitar</surname><given-names>AN</given-names></name>
<name><surname>Maver</surname><given-names>A</given-names></name>
</person-group><article-title>No specific gene expression signature in human granulosa and cumulus cells for prediction of oocyte fertilisation and embryo implantation</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>3</issue><fpage>e0115865</fpage><lpage>e0115865</lpage><pub-id pub-id-type="pmid">25769026</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feuerstein</surname><given-names>P</given-names></name>
<name><surname>Cadoret</surname><given-names>V</given-names></name>
<name><surname>Dalbies-Tran</surname><given-names>R</given-names></name>
<name><surname>Guerif</surname><given-names>F</given-names></name>
<name><surname>Bidault</surname><given-names>R</given-names></name>
<name><surname>Royere</surname><given-names>D</given-names></name>
</person-group><article-title>Gene expression in human cumulus cells: one approach to oocyte competence</article-title><source>Hum Reprod</source><year>2007</year><volume>22</volume><issue>12</issue><fpage>3069</fpage><lpage>3077</lpage><pub-id pub-id-type="pmid">17951581</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Belli</surname><given-names>M</given-names></name>
<name><surname>Shimasaki</surname><given-names>S</given-names></name>
</person-group><article-title>Molecular aspects and clinical relevance of GDF9 and BMP15 in ovarian function</article-title><source>Vitam Horm</source><year>2018</year><volume>107</volume><fpage>317</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">29544636</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raja-Khan</surname><given-names>N</given-names></name>
<name><surname>Urbanek</surname><given-names>M</given-names></name>
<name><surname>Rodgers</surname><given-names>RJ</given-names></name>
<name><surname>Legro</surname><given-names>RS</given-names></name>
</person-group><article-title>The role of TGF-&#x003b2; in polycystic ovary syndrome</article-title><source>Reprod Sci</source><year>2014</year><volume>21</volume><issue>1</issue><fpage>20</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">23585338</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Romanski</surname><given-names>PA</given-names></name>
<name><surname>Brady</surname><given-names>PC</given-names></name>
<name><surname>Farland</surname><given-names>LV</given-names></name>
<name><surname>Thomas</surname><given-names>AM</given-names></name>
<name><surname>Hornstein</surname><given-names>MD</given-names></name>
</person-group><article-title>The effect of endometriosis on the antim&#x000fc;llerian hormone level in the infertile population</article-title><source>J Assist Reprod Genet</source><year>2019</year><volume>36</volume><issue>6</issue><fpage>1179</fpage><lpage>1184</lpage><pub-id pub-id-type="pmid">31020439</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Houten</surname><given-names>EL</given-names></name>
<name><surname>Themmen</surname><given-names>AP</given-names></name>
<name><surname>Visser</surname><given-names>JA</given-names></name>
</person-group><article-title>Anti-M&#x000fc;llerian hormone (AMH): regulator and marker of ovarian function</article-title><source>Ann Endocrinol (Paris)</source><year>2010</year><volume>71</volume><issue>3</issue><fpage>191</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">20362961</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rybska</surname><given-names>M</given-names></name>
<name><surname>Knap</surname><given-names>S</given-names></name>
<name><surname>Stefa&#x00144;ska</surname><given-names>K</given-names></name>
<name><surname>Jankowski</surname><given-names>M</given-names></name>
<name><surname>Chamier- Gliszczy&#x00144;ska</surname><given-names>A</given-names></name>
<name><surname>Popis</surname><given-names>M</given-names></name>
<etal/>
</person-group><article-title>Transforming growth factor (TGF) - is it a key protein in mammalian reproductive biology?</article-title><source>Med J Cell Biol</source><year>2018</year><volume>6</volume><issue>3</issue><fpage>125</fpage><lpage>30</lpage></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>B</given-names></name>
<name><surname>Wu</surname><given-names>X</given-names></name>
<name><surname>Yuan</surname><given-names>Y</given-names></name>
<name><surname>Gao</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Du</surname><given-names>R</given-names></name>
<etal/>
</person-group><article-title>Gene expression of granulosa and cumulus cells: The prospect in predicting the quality and developmental competence of oocytes in vitro maturation</article-title><source>Biocell</source><year>2020</year><volume>44</volume><issue>4</issue><fpage>487</fpage><lpage>499</lpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dumesic</surname><given-names>DA</given-names></name>
<name><surname>Meldrum</surname><given-names>DR</given-names></name>
<name><surname>Katz-Jaffe</surname><given-names>MG</given-names></name>
<name><surname>Krisher</surname><given-names>RL</given-names></name>
<name><surname>Schoolcraft</surname><given-names>WB</given-names></name>
</person-group><article-title>Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health</article-title><source>Fertil Steril</source><year>2015</year><volume>103</volume><issue>2</issue><fpage>303</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">25497448</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Field</surname><given-names>SL</given-names></name>
<name><surname>Dasgupta</surname><given-names>T</given-names></name>
<name><surname>Cummings</surname><given-names>M</given-names></name>
<name><surname>Orsi</surname><given-names>NM</given-names></name>
</person-group><article-title>Cytokines in ovarian folliculogenesis, oocyte maturation and luteinisation</article-title><source>Mol Reprod Dev</source><year>2014</year><volume>81</volume><issue>4</issue><fpage>284</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">24273059</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lv</surname><given-names>P-P</given-names></name>
<name><surname>Jin</surname><given-names>M</given-names></name>
<name><surname>Rao</surname><given-names>J-P</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>L-Q</given-names></name>
<name><surname>Huang</surname><given-names>C-C</given-names></name>
<etal/>
</person-group><article-title>Role of anti-M&#x000fc;llerian hormone and testosterone in follicular growth: a cross-sectional study</article-title><source>BMC Endocr Disord</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>101</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">32641160</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sanfins</surname><given-names>A</given-names></name>
<name><surname>Rodrigues</surname><given-names>P</given-names></name>
<name><surname>Albertini</surname><given-names>DF</given-names></name>
</person-group><article-title>GDF-9 and BMP-15 direct the follicle symphony</article-title><source>J Assist Reprod Genet</source><year>2018</year><volume>35</volume><issue>10</issue><fpage>1741</fpage><lpage>1750</lpage><pub-id pub-id-type="pmid">30039232</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hosseini</surname><given-names>E</given-names></name>
<name><surname>Shahhoseini</surname><given-names>M</given-names></name>
<name><surname>Afsharian</surname><given-names>P</given-names></name>
<name><surname>Karimian</surname><given-names>L</given-names></name>
<name><surname>Ashrafi</surname><given-names>M</given-names></name>
<name><surname>Mehraein</surname><given-names>F</given-names></name>
<etal/>
</person-group><article-title>Role of epigenetic modifications in the aberrant CYP19A1 gene expression in polycystic ovary syndrome</article-title><source>Arch Med Sci</source><year>2019</year><volume>15</volume><issue>4</issue><fpage>887</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">31360184</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hosseini</surname><given-names>E</given-names></name>
<name><surname>Mehraein</surname><given-names>F</given-names></name>
<name><surname>Shahhoseini</surname><given-names>M</given-names></name>
<name><surname>Karimian</surname><given-names>L</given-names></name>
<name><surname>Nikmard</surname><given-names>F</given-names></name>
<name><surname>Ashrafi</surname><given-names>M</given-names></name>
<etal/>
</person-group><article-title>Epigenetic alterations of CYP19A1 gene in Cumulus cells and its relevance to infertility in endometriosis</article-title><source>J Assist Reprod Genet</source><year>2016</year><volume>33</volume><issue>8</issue><fpage>1105</fpage><lpage>1113</lpage><pub-id pub-id-type="pmid">27167072</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andrei</surname><given-names>D</given-names></name>
<name><surname>Nagy</surname><given-names>RA</given-names></name>
<name><surname>van Montfoort</surname><given-names>A</given-names></name>
<name><surname>Tietge</surname><given-names>U</given-names></name>
<name><surname>Terpstra</surname><given-names>M</given-names></name>
<name><surname>Kok</surname><given-names>K</given-names></name>
<etal/>
</person-group><article-title>Differential miRNA expression profiles in cumulus and mural granulosa cells from human pre-ovulatory follicles</article-title><source>MicroRNA</source><year>2019</year><volume>8</volume><issue>1</issue><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">30207252</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Turathum</surname><given-names>B</given-names></name>
<name><surname>Gao</surname><given-names>EM</given-names></name>
<name><surname>Chian</surname><given-names>RC</given-names></name>
</person-group><article-title>The function of cumulus cells in oocyte growth and maturation and in subsequent ovulation and fertilization</article-title><source>Cells</source><year>2021</year><volume>10</volume><issue>9</issue><fpage>2292</fpage><lpage>2292</lpage><pub-id pub-id-type="pmid">34571941</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Z</given-names></name>
<name><surname>Wells</surname><given-names>D</given-names></name>
</person-group><article-title>The human oocyte and cumulus cells relationship: new insights from the cumulus cell transcriptome</article-title><source>Mol Hum Reprod</source><year>2010</year><volume>16</volume><issue>10</issue><fpage>715</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">20435609</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ouandaogo</surname><given-names>ZG</given-names></name>
<name><surname>Haouzi</surname><given-names>D</given-names></name>
<name><surname>Assou</surname><given-names>S</given-names></name>
<name><surname>Dechaud</surname><given-names>H</given-names></name>
<name><surname>Kadoch</surname><given-names>IJ</given-names></name>
<name><surname>De Vos</surname><given-names>J</given-names></name>
<etal/>
</person-group><article-title>Human cumulus cells molecular signature in relation to oocyte nuclear maturity stage</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>11</issue><fpage>e27179</fpage><lpage>e27179</lpage><pub-id pub-id-type="pmid">22087263</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Assidi</surname><given-names>M</given-names></name>
<name><surname>Dieleman</surname><given-names>SJ</given-names></name>
<name><surname>Sirard</surname><given-names>M-A</given-names></name>
</person-group><article-title>Cumulus cell gene expression following the LH surge in bovine preovulatory follicles: potential early markers of oocyte competence</article-title><source>Reproduction</source><year>2010</year><volume>140</volume><issue>6</issue><fpage>835</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">20724459</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khalaf</surname><given-names>M</given-names></name>
<name><surname>Morera</surname><given-names>J</given-names></name>
<name><surname>Bourret</surname><given-names>A</given-names></name>
<name><surname>Reznik</surname><given-names>Y</given-names></name>
<name><surname>Denoual</surname><given-names>C</given-names></name>
<name><surname>Herlicoviez</surname><given-names>M</given-names></name>
<etal/>
</person-group><article-title>BMP system expression in G.C.s from polycystic ovary syndrome women and the in vitro effects of BMP4, BMP6, and BMP7 on GC steroidogenesis</article-title><source>Eur J Endocrinol</source><year>2013</year><volume>168</volume><issue>3</issue><fpage>437</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">23243014</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Paradis</surname><given-names>F</given-names></name>
<name><surname>Novak</surname><given-names>S</given-names></name>
<name><surname>Murdoch</surname><given-names>GK</given-names></name>
<name><surname>Dyck</surname><given-names>MK</given-names></name>
<name><surname>Dixon</surname><given-names>WT</given-names></name>
<name><surname>Foxcroft</surname><given-names>GR</given-names></name>
</person-group><article-title>Temporal regulation of BMP2, BMP6, BMP15, GDF9, BMPR1A, BMPR1B, BMPR2 and TGFBR1 mRNA expression in the oocyte, granulosa and theca cells of developing preovulatory follicles in the pig</article-title><source>Reproduction</source><year>2009</year><volume>138</volume><issue>1</issue><fpage>115</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">19359354</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>C</given-names></name>
<name><surname>Wang</surname><given-names>P</given-names></name>
<name><surname>DeMayo</surname><given-names>J</given-names></name>
<name><surname>DeMayo</surname><given-names>FJ</given-names></name>
<name><surname>Elvin</surname><given-names>JA</given-names></name>
<name><surname>Carino</surname><given-names>C</given-names></name>
<etal/>
</person-group><article-title>Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function</article-title><source>Mol Endocrinol</source><year>2001</year><volume>15</volume><issue>6</issue><fpage>854</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">11376106</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kedem-Dickman</surname><given-names>A</given-names></name>
<name><surname>Maman</surname><given-names>E</given-names></name>
<name><surname>Yung</surname><given-names>Y</given-names></name>
<name><surname>Yerushalmi</surname><given-names>G</given-names></name>
</person-group><article-title>M., Hemi R, Hanochi M, et al.Anti-M&#x000fc;llerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes</article-title><source>Reprod Biomed Online</source><year>2012</year><volume>24</volume><issue>5</issue><fpage>540</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">22421733</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nilsson</surname><given-names>EE</given-names></name>
<name><surname>Schindler</surname><given-names>R</given-names></name>
<name><surname>Savenkova</surname><given-names>MI</given-names></name>
<name><surname>Skinner</surname><given-names>MK</given-names></name>
</person-group><article-title>Inhibitory actions of Anti-M&#x000fc;llerian Hormone (AMH) on ovarian primordial follicle assembly</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>5</issue><fpage>e20087</fpage><lpage>e20087</lpage><pub-id pub-id-type="pmid">21637711</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sacchi</surname><given-names>S</given-names></name>
<name><surname>&#x02018;D&#x02019;Ippolito</surname><given-names>G</given-names></name>
<name><surname>Sena</surname><given-names>P</given-names></name>
<name><surname>Marsella</surname><given-names>T</given-names></name>
<name><surname>Tagliasacchi</surname><given-names>D</given-names></name>
<name><surname>Maggi</surname><given-names>E</given-names></name>
<etal/>
</person-group><article-title>The anti-M&#x000fc;llerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH</article-title><source>J Assist Reprod Genet</source><year>2016</year><volume>33</volume><issue>1</issue><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">26631403</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pasquali</surname><given-names>R</given-names></name>
</person-group><article-title>New perspectives on the role of anti-M&#x000fc;llerian hormone (AMH) in women</article-title><source>Ann Transl Med</source><year>2018</year><volume>6</volume><issue>Suppl 2</issue><fpage>s94</fpage><lpage>s94</lpage><pub-id pub-id-type="pmid">30740415</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Capuzzo</surname><given-names>M</given-names></name>
<name><surname>La Marca</surname><given-names>A</given-names></name>
</person-group><article-title>Use of AMH in the differential diagnosis of anovulatory disorders including PCOS</article-title><source>Front Endocrinol (Lausanne)</source><year>2021</year><volume>11</volume><fpage>616766</fpage><lpage>616766</lpage><pub-id pub-id-type="pmid">33633686</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fr&#x000e9;our</surname><given-names>T</given-names></name>
<name><surname>Miralli&#x000e9;</surname><given-names>S</given-names></name>
<name><surname>Colombel</surname><given-names>A</given-names></name>
<name><surname>Bach-Ngohou</surname><given-names>K</given-names></name>
<name><surname>Masson</surname><given-names>D</given-names></name>
<name><surname>Barri&#x000e8;re</surname><given-names>P</given-names></name>
</person-group><article-title>Anti-mullerian hormone: clinical relevance in assisted reproductive therapy</article-title><source>Ann Endocrinol</source><year>2006</year><volume>67</volume><issue>6</issue><fpage>567</fpage><lpage>574</lpage></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garg</surname><given-names>D</given-names></name>
<name><surname>Tal</surname><given-names>R</given-names></name>
</person-group><article-title>The role of AMH in the pathophysiology of polycystic ovarian syndrome</article-title><source>Reprod Biomed Online</source><year>2016</year><volume>33</volume><issue>1</issue><fpage>15</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">27174394</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oh</surname><given-names>SR</given-names></name>
<name><surname>Choe</surname><given-names>SY</given-names></name>
<name><surname>Cho</surname><given-names>YJ</given-names></name>
</person-group><article-title>Clinical application of serum anti-M&#x000fc;llerian hormone in women</article-title><source>Clin Exp Reprod Med</source><year>2019</year><volume>46</volume><issue>2</issue><fpage>50</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">31181872</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pellatt</surname><given-names>L</given-names></name>
<name><surname>Hanna</surname><given-names>L</given-names></name>
<name><surname>Brincat</surname><given-names>M</given-names></name>
<name><surname>Galea</surname><given-names>R</given-names></name>
<name><surname>Brain</surname><given-names>H</given-names></name>
<name><surname>Whitehead</surname><given-names>S</given-names></name>
<etal/>
</person-group><article-title>Granulosa cell production of anti-mullerian hormone is increased in polycystic ovaries</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><issue>1</issue><fpage>240</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">17062765</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ogura-Nose</surname><given-names>S</given-names></name>
<name><surname>Yoshino</surname><given-names>O</given-names></name>
<name><surname>Osuga</surname><given-names>Y</given-names></name>
<name><surname>Shi</surname><given-names>J</given-names></name>
<name><surname>Hiroi</surname><given-names>H</given-names></name>
<name><surname>Yano</surname><given-names>T</given-names></name>
<etal/>
</person-group><article-title>Anti-mullerian hormone (AMH) is induced by bone morphogenetic protein (BMP) cytokines in human granulosa cells</article-title><source>Eur J Obstet Gynecol Reprod Biol</source><year>2012</year><volume>164</volume><issue>1</issue><fpage>44</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">22682966</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Estienne</surname><given-names>A</given-names></name>
<name><surname>Pierre</surname><given-names>A</given-names></name>
<name><surname>di Clemente</surname><given-names>N</given-names></name>
<name><surname>Picard</surname><given-names>JY</given-names></name>
<name><surname>Jarrier</surname><given-names>P</given-names></name>
<name><surname>Mansanet</surname><given-names>C</given-names></name>
<etal/>
</person-group><article-title>Anti-M&#x000fc;llerian hormone regulation by the bone morphogenetic proteins in the sheep ovary: deciphering a direct regulatory pathway</article-title><source>Endocrinology</source><year>2015</year><volume>156</volume><issue>1</issue><fpage>301</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">25322464</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Chen</surname><given-names>H</given-names></name>
<name><surname>Gou</surname><given-names>M</given-names></name>
<name><surname>Tian</surname><given-names>C</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Song</surname><given-names>X</given-names></name>
<etal/>
</person-group><source>Comprehensive molecular features of polycystic ovary syndrome revealed by transcriptome analysis of oocytes and cumulus cells.bioRxiv</source><publisher-name>bioRxiv</publisher-name><year>2021</year></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rosenfield</surname><given-names>RL</given-names></name>
<name><surname>Ehrmann</surname><given-names>DA</given-names></name>
</person-group><article-title>The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited</article-title><source>Endocr Rev</source><year>2016</year><volume>37</volume><issue>5</issue><fpage>467</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">27459230</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>S&#x000e8;des</surname><given-names>L</given-names></name>
<name><surname>Leclerc</surname><given-names>A</given-names></name>
<name><surname>Moindjie</surname><given-names>H</given-names></name>
<name><surname>Cate</surname><given-names>RL</given-names></name>
<name><surname>Picard</surname><given-names>JsY</given-names></name>
<name><surname>Di Clemente</surname><given-names>N</given-names></name>
<etal/>
</person-group><article-title>Anti-M&#x000fc;llerian hormone recruits BMPR-IA in immature granulosa cells</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>11</issue><fpage>e81551</fpage><lpage>e81551</lpage><pub-id pub-id-type="pmid">24312319</pub-id></element-citation></ref></ref-list></back></article>
